Edition:
United Kingdom

ContraVir Pharmaceuticals Inc (CTRV.OQ)

CTRV.OQ on NASDAQ Stock Exchange Capital Market

0.37USD
11 Dec 2017
Change (% chg)

$-0.05 (-12.24%)
Prev Close
$0.42
Open
$0.41
Day's High
$0.41
Day's Low
$0.35
Volume
379,725
Avg. Vol
188,548
52-wk High
$2.06
52-wk Low
$0.35

Select another date:

Tue, Oct 17 2017

BRIEF-Contravir Pharmaceuticals enters research collaboration with Li Ka Shing Institute of Virology

* Contravir Pharmaceuticals announces research collaboration agreement with Li Ka Shing Institute of Virology Source text for Eikon: Further company coverage: (Reporting by Sruthi Ramakrishnan)

BRIEF-Contravir Pharmaceuticals receives HBV IND approval for tenofovir exalidex in the U.S.

* Contravir Pharmaceuticals receives hbv ind approval for tenofovir exalidex (txl™) in the United States

BRIEF-U.K. accepts Contravir Pharma's clinical trial application

* Contravir Pharmaceuticals announces acceptance of clinical trial application in the United Kingdom

BRIEF-ContraVir Pharmaceuticals announces issuance of new U.S. patent for expansion of cyclophilin inhibitor program

* ContraVir Pharmaceuticals announces issuance of new US patent for expansion of cyclophilin inhibitor program

Select another date: